Trial · NCT01387594
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Cohort 2: Baseline Absolute Lymphocyte Count in Cerebrospinal Fluid (CSF) | Cohort 2: PF-00547659 | 338.5 | Full Range 689.69 | cells per milliliter (cells/mL) | |
| Cohort 2: Percent Change From Baseline in Absolute Lymphocyte Count in CSF at Month 3 | Cohort 2: PF-00547659 | 35.2 | Full Range 92.67 | percent change | |
Cohorts 1 and 2: Total Number of Participants With Non-Lumbar Puncture (LP) Related Treatment-Emergent Adverse Events (AEs), Withdrawals Due to AEs, and Serious Adverse Events (SAEs) During the 12-week Treatment Period | Cohort 1: PF-00547659 | AEs | 9 | participants | |
Cohorts 1 and 2: Total Number of Participants With Non-Lumbar Puncture (LP) Related Treatment-Emergent Adverse Events (AEs), Withdrawals Due to AEs, and Serious Adverse Events (SAEs) During the 12-week Treatment Period | Cohort 2: PF-00547659 | AEs | 36 | participants | |
Cohorts 1 and 2: Total Number of Participants With Non-Lumbar Puncture (LP) Related Treatment-Emergent Adverse Events (AEs), Withdrawals Due to AEs, and Serious Adverse Events (SAEs) During the 12-week Treatment Period | Cohort 1: PF-00547659 | Withdrawals due to AEs | 0 | participants | |
Cohorts 1 and 2: Total Number of Participants With Non-Lumbar Puncture (LP) Related Treatment-Emergent Adverse Events (AEs), Withdrawals Due to AEs, and Serious Adverse Events (SAEs) During the 12-week Treatment Period | Cohort 2: PF-00547659 | Withdrawals due to AEs | 0 | participants | |
Cohorts 1 and 2: Total Number of Participants With Non-Lumbar Puncture (LP) Related Treatment-Emergent Adverse Events (AEs), Withdrawals Due to AEs, and Serious Adverse Events (SAEs) During the 12-week Treatment Period | Cohort 1: PF-00547659 | SAEs | 1 | participants | |
Cohorts 1 and 2: Total Number of Participants With Non-Lumbar Puncture (LP) Related Treatment-Emergent Adverse Events (AEs), Withdrawals Due to AEs, and Serious Adverse Events (SAEs) During the 12-week Treatment Period | Cohort 2: PF-00547659 | SAEs | 3 | participants | |
| Cohorts 1 and 2: Number of Participants Who Developed Anti-Drug Antibodies (ADAs) to PF-00547659 | Cohort 1: PF-00547659 | 4 | participants | ||
| Cohorts 1 and 2: Number of Participants Who Developed Anti-Drug Antibodies (ADAs) to PF-00547659 | Cohort 2: PF-00547659 | 11 | participants | ||
| Cohorts 1 and 2: Number of Participants With Injection Site Reactions by Severity | Cohort 1: PF-00547659 | Mild | 1 | participants | |
| Cohorts 1 and 2: Number of Participants With Injection Site Reactions by Severity | Cohort 2: PF-00547659 | Mild | 6 | participants | |
| Cohorts 1 and 2: Number of Participants With Injection Site Reactions by Severity | Cohort 1: PF-00547659 | Moderate | 0 | participants | |
| Cohorts 1 and 2: Number of Participants With Injection Site Reactions by Severity | Cohort 2: PF-00547659 | Moderate | 1 | participants | |
| Cohorts 1 and 2: Number of Participants With Injection Site Reactions by Severity | Cohort 1: PF-00547659 | Severe | 0 | participants | |
| Cohorts 1 and 2: Number of Participants With Injection Site Reactions by Severity | Cohort 2: PF-00547659 | Severe | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01387594/results